Analyst Recommendations

Jefferies analyst issues BUY recommendation for VEEV on March 4, 2024 07:56AM ET. The previous analyst recommendation was Buy.VEEV was trading at $222.01 at issue of the analyst...

March 4, 2024   VEEV -0.17%

Wells Fargo analyst issues OVERWEIGHT recommendation for CRWD on March 4, 2024 07:56AM ET. The previous analyst recommendation was Overweight.CRWD was trading at $314.6 at issue of the...

March 4, 2024   CRWD 1.52%

Cowen & Co. analyst issues OUTPERFORM recommendation for MTZ on March 4, 2024 07:56AM ET. The previous analyst recommendation was Outperform.MTZ was trading at $84.85 at issue of...

March 4, 2024   MTZ 1.46%

Needham analyst issues BUY recommendation for RXRX on March 4, 2024 08:02AM ET. The previous analyst recommendation was Buy.RXRX was trading at $12.81 at issue of the analyst...

March 4, 2024   RXRX 3.63%

Cowen & Co. analyst issues NEUTRAL recommendation for QURE on March 4, 2024 07:56AM ET. The previous analyst recommendation was Neutral.QURE was trading at $5.59 at issue of...

March 4, 2024   QURE -0.73%

Telsey Advisory analyst issues MARKET PERFORM recommendation for OLPX on March 4, 2024 09:01AM ET. The previous analyst recommendation was Market Perform.OLPX was trading at $1.82 at issue...

March 4, 2024   OLPX 0.45%

Wedbush analyst issues UNDERPERFORM recommendation for AMD on March 4, 2024 07:00AM ET. The previous analyst recommendation was Underperform.AMD was trading at $202.64 at issue of the analyst...

March 4, 2024   AMD 1.54%

Susquehanna analyst issues UNDERPERFORM recommendation for EPAM on March 4, 2024 07:00AM ET. The previous analyst recommendation was Underperform.EPAM was trading at $306.83 at issue of the analyst...

March 4, 2024   EPAM 1.36%

Wells Fargo analyst issues BUY recommendation for COST on March 4, 2024 07:00AM ET. The previous analyst recommendation was Buy.COST was trading at $749.44 at issue of the...

March 4, 2024   COST 0.59%

UBS analyst issues UNDERPERFORM recommendation for COST on March 4, 2024 07:00AM ET. The previous analyst recommendation was Underperform.COST was trading at $749.44 at issue of the analyst...

March 4, 2024   COST 0.59%